Title
|
Type
|
Submission Type |
Organizer |
Cosponsor |
Description |
General Posters |
Poster |
Contributed |
|
|
|
Sci-Mix |
Poster |
Contributed |
|
|
|
Academic Drug Discovery |
Oral |
Invited |
|
|
|
Besides Off Rate: The Importance of On Rate & Target Rebinding |
Oral |
Invited |
|
|
|
Covalent Inhibition beyond Cysteine |
Oral |
Invited |
|
|
|
Exploring Cryptic Pockets |
Oral |
Invited |
|
|
|
First Time Disclosure of Clinical Candidates |
Oral |
Invited |
|
|
|
General Orals |
Oral |
Contributed |
|
|
|
Ions Count: Acids, Bases & Zwitterionics in Drug Design (Medicinal Chemists' Toolbox Series) |
Oral |
Invited |
|
|
|
MEDI Awards Symposium |
Oral |
Invited |
|
|
|
Recent Advances in Targeting Oncogenic KRAS |
Oral |
Invited |
|
|
|
Small Molecule Immunomodulators in Cancer |
Oral |
Invited |
|
|
|
Small Molecule Therapeutics for Neuro-oncology |
Oral |
Invited |
|
|
|
Synthetic Technologies to Enable Medicinal Chemistry |
Oral |
Invited |
|
|
|
Targeted Protein Degradation: A Small Molecule Game-Changer for Medicine Discovery |
Oral |
Invited |
|
|
|
The Messy Business of Target (In)Validation: Chemistry's Role & Challenges in Early Discovery |
Oral |
Invited |
|
|
|
Therapeutic Developments in Health Disparities |
Oral |
Invited |
|
|
|